What are the side effects of Liqenza 32mg Solution?

Liqenza 32mg Solution can cause some adverse impacts, including fever, nausea, chills, skin rash, itching, vomiting, swelling on the face, diarrhea, anemia, etc. Contact a doctor if you experience any serious effects

Is it safe to drive after taking Liqenza 32mg Solution?

Avoid driving while taking this medicine, as it may cause side effects such as dizziness and lack of concentration.

Is it safe to take Liqenza 32mg Solution during pregnancy or breastfeeding?

Liqenza 32mg Solution consumption is not recommended in women during pregnancy and breastfeeding.

How long should I take the Liqenza 32mg Solution?

The duration of the medicine is usually decided by the doctor according to the patient's health condition.

Buy Liqenza 32mg Solution Online: Price, 23% Discount, Uses, and Side Effects

Description

Liqenza 32mg Solution is an anticancer medicine. It contains Enzalutamide as an active ingredient that belongs to the second-generation nonsteroidal antiandrogen class of drugs.

It prescribes to treat prostate cancer in men at various stages. It may also be used to treat some other conditions like PCOS, as determined by the doctor.

Liqenza works by blocking the effects of male hormones such as testosterone to slow down the growth and multiplication of cancer cells. It should be taken in dose and duration as advice by the doctor.

Don't take more than the recommended dose

Uses

Prostate cancer
Polycystic ovarian syndrome (PCOS)
Excessive hair growth

Side Effects

Liqenza 32mg Solution may cause some side effects that vary from one patient to another. Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.

Common side effects include:

Headache
Hot flashes
Weakness
High blood pressure
Fatigue
Decreased appetite
Constipation
Dry skin
Itching
Fall
Fracture

Seek medical attention in case of any unusual or severe side effects immediately.

How To Use

Take Liqenza 32mg Solution in exact dose as prescribed by the doctor. The typical dose of this capsule varies with age and overall health factor of the patient. It can be taken with or without food but at a fixed time each day to get better results.
It should be swallowed as a whole with water without crushing, chewing, or opening the capsule. Don't miss a dose or overdose the medicine.

How It Works

Liqenza 32mg Solution contains Enzalutamide (160mg) as an active ingredient that belongs to the second-generation nonsteroidal antiandrogen class of drugs.
It works by blocking the action of a particular enzyme to reduce the production of male hormone like testosterone. As a result, by controlling the production of hormone it slows down the progression of cancer.

Safety Advice

Alcohol

Avoid the consumption of alcohol while taking Liqenza 32mg Solution, as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms.

Pregnancy

Do not take Liqenza 32mg Solution without consulting the doctor in case of pregnancy, as it can be unsafe to take it during this period.

Breast Feeding

Breastfeeding women should discuss the potential risks and benefits of the Liqenza 32mg Solution with their healthcare provider before starting treatment.

Driving

Liqenza 32mg Solution may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.

Kidney

Share your medical history with the doctor before starting the Liqenza 32mg Solution. Do not take it without consulting a doctor if you have any kidney related issue.

Liver

Share your medical history with the doctor before starting the Liqenza 32mg Solution. Do not take it without consulting a doctor if you have any liver related issue.

FAQs

Liqenza 32mg Solution is an anti-cancer medication that is prescribed for the treatment of Prostate cancer.

It works by blocking the effect of testosterone.

References

Freedland, S. J., de Almeida Luz, M., De Giorgi, U., Gleave, M., Gotto, G. T., Pieczonka, C. M., ... & Shore, N. D. (2023). Improved outcomes with enzalutamide in biochemically recurrent prostate cancer. New England Journal of Medicine, 389(16), 1453-1465. https://pubmed.ncbi.nlm.nih.gov/37851874/
Hoffman-Censits, J., & Kelly, W. K. (2013). Enzalutamide: a novel antiandrogen for patients with castrate-resistant prostate cancer. Clinical Cancer Research, 19(6), 1335-1339. https://pubmed.ncbi.nlm.nih.gov/23300275/
Claessens, F., Helsen, C., Prekovic, S., Van den Broeck, T., Spans, L., Van Poppel, H., & Joniau, S. (2014). Emerging mechanisms of enzalutamide resistance in prostate cancer. Nature reviews urology, 11(12), 712-716. https://pubmed.ncbi.nlm.nih.gov/25224448/
Davis, I. D., Martin, A. J., Stockler, M. R., Begbie, S., Chi, K. N., Chowdhury, S., ... & Sweeney, C. J. (2019). Enzalutamide with standard first-line therapy in metastatic prostate cancer. New England Journal of Medicine, 381(2), 121-131.
Beer, T. M., Armstrong, A. J., Rathkopf, D. E., Loriot, Y., Sternberg, C. N., Higano, C. S., ... & Tombal, B. (2014). Enzalutamide in metastatic prostate cancer before chemotherapy. New England Journal of Medicine, 371(5), 424-433.

Liqenza 32mg Solution

About The Product